DRUG DISCOVERY LABORATORY AS

1166 OSLO

Finances

Return on Equity

25,99 %

Current Ratio

6,92

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	2 257 000	1 482 000	1 282 000	2 087 000
Net Income	1 430 000	857 000	265 000	416 000
Total Assets	6 364 000	4 506 000	3 988 000	6 676 000
Total Equity	5 502 000	4 073 000	3 515 000	6 251 000

Income (NOK)	2022	2021	2020	2019
Revenue	2 257 000	1 482 000	1 282 000	2 087 000
Expenditure	425 000	390 000	694 000	1 550 000
Operating Profit	1 832 000	1 092 000	587 000	538 000
Financial Income	4 000	2 000	17 000	2 918 000
Financial Costs	5 000	0	200 000	2 985 000
Financial Balance	−1 000	2 000	−183 000	−67 000
Earnings Before Tax	1 831 000	1 094 000	404 000	471 000
Tax	401 000	237 000	140 000	55 000
Net Income	1 430 000	857 000	265 000	416 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	409 000	415 000	335 000	488 000
Total Current Assets	5 954 000	4 092 000	3 654 000	6 188 000
Total Assets	6 364 000	4 506 000	3 988 000	6 676 000
Total Retained Equity	5 402 000	3 973 000	3 415 000	5 542 000
Total Equity	5 502 000	4 073 000	3 515 000	6 251 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	861 000	434 000	473 000	425 000
Total Equity and Debt	6 364 000	4 506 000	3 988 000	6 676 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	2 257 000	1 482 000	1 336 000	1 570 000
Other Income	0	0	−54 000	517 000
Revenue	2 257 000	1 482 000	1 282 000	2 087 000
Cost of Goods Sold	0	0	21 000	119 000
Salary Costs	329 000	328 000	335 000	849 000
Depreciation	0	0	53 000	53 000
Impairment	0	0	0	0
Expenditure	425 000	390 000	694 000	1 550 000
Operating Profit	1 832 000	1 092 000	587 000	538 000
Financial Income	4 000	2 000	17 000	2 918 000
Financial Costs	5 000	0	200 000	2 985 000
Financial Balance	−1 000	2 000	−183 000	−67 000
Dividends	0	300 000	3 000 000	0
Net Income	1 430 000	857 000	265 000	416 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	53 000
Total Tangible Assets	0	0	0	53 000
Total Fiancial Fixed Assets	409 000	415 000	335 000	434 000
Total Fixed Assets	409 000	415 000	335 000	488 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	5 109 000	3 871 000	3 151 000	5 978 000
Total Current Assets	5 954 000	4 092 000	3 654 000	6 188 000
Total Assets	6 364 000	4 506 000	3 988 000	6 676 000
Total Equity	5 502 000	4 073 000	3 515 000	6 251 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	43 000	28 000	44 000	29 000
Unpaid Taxes	388 000	139 000	124 000	138 000
Dividends	0	300 000	3 000 000	0
Other Current Debt	29 000	29 000	166 000	203 000
Total Current Debt	861 000	434 000	473 000	425 000
Total Equity and Debt	6 364 000	4 506 000	3 988 000	6 676 000

Financial indicators	2022	2021	2020	2019
Return on Equity	25,99 %	21,04 %	7,54 %	6,65 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	81,17 %	73,68 %	45,79 %	25,78 %
Current Ratio	6,92	9,43	7,73	14,56
Quick Ratio	6,92	9,43	7,73	14,56
Equity Ratio	0,86	0,9	0,88	0,94
Gross Profit Margin	100 %	100 %	98,36 %	94,3 %